1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CYP2D6 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA ADARB2 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA CAST CTRPv2 pan-cancer AAC -0.16 6e-06
mRNA TADA1 CTRPv2 pan-cancer AAC 0.17 6e-06
mRNA KNTC1 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA LIG1 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA TCF20 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA DIRAS1 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA PSMA7 CTRPv2 pan-cancer AAC -0.15 6e-06
mRNA ZNF337 CTRPv2 pan-cancer AAC 0.15 6e-06
Download CSV